Search Result "Disease duration"
Sleep Duration as a Risk Factor for Cardiovascular Disease- a Review of the Recent Literature
Journal: Current Cardiology Reviews
Volume: 6 Issue: 1 Year: 2010 Page: 54-61
Author(s): Michiaki Nagai, Satoshi Hoshide, Kazuomi Kario
Atrial Fibrillation Recurrence: The Roles of Hypertension, Duration of Atrial Fibrillation Disease, and Prolonged Signal-Averaged P Wave Duration
Journal: Current Cardiology Reviews
Volume: 1 Issue: 2 Year: 2005 Page: 103-108
Author(s): Ulrik Dixen, Annette Hoegh, Jan Parner, Verner Rasmussen, Steen M. Pehrson, Gorm B. Jensen
Stent Thrombosis and Duration of Dual Antiplatelet Therapy
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 4052-4063
Author(s): Alfonso Ielasi, Rasha Al-Lamee, Antonio Colombo
Association between Sleep Duration and Early Pubertal Timing in Children and Adolescents: A Systematic Review and Meta-analysis
Journal: Current Pediatric Reviews
Volume: 19 Issue: 3 Year: 2023 Page: 318-328
Author(s): Mohammad Reza Maracy
The Impact of Tracheostomy Timing on the Duration and Complications of Mechanical Ventilation
Journal: Current Respiratory Medicine Reviews
Volume: 15 Issue: 4 Year: 2019 Page: 272-280
Author(s): Renata de Souza Zaponi,Erica Fernanda Osaku,Lilian Regina Lengler Abentroth,Mayara Manzoni Marques da Silva,Jaiane Luiza Jaskowiak,Suely Mariko Ogasawara,Marcela Aparecida Leite,Cláudia Rejane Lima de Macedo Costa,Itamar Regazzo Pedreschi Porto,Amaury Cezar Jorge,Pericles Almeida Delfino Duarte
Efficacy and Safety Outcomes of Short Duration Antiplatelet Therapywith Early Cessation of Aspirin Post Percutaneous Coronary Intervention:A Systematic Review and Meta-analysis
Journal: Current Cardiology Reviews
Volume: 17 Issue: 6 Year: 2021 Page: 10-20
Author(s): Firas R. AL-Obaidi,Hayley A. Hutchings,Andy S.C. Yong,Hasan Al-Farhan,Mohammed H. Al-Ali,Tahsin Al-Kinani,Mohammed Al-Myahi,Hussein Al-Kenzawi,Nazar Al-Sudani
Comparative Efficacy and Safety of Duration of Dual Antiplatelet Therapy in Patients with CAD Undergoing Drug-eluting Stent Implantation: A Systematic Review and Network Meta-analysis
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 44 Year: 2020 Page: 5739-5745
Author(s): Jieqiong Guan,Wenjing Song,Pan He,Siyu Fan,Hong Zhi,Lina Wang
Duration of Dual Antiplatelet Therapy After Coronary Stenting
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 2 Year: 2016 Page: 4583-4595
Author(s): Gerasimos Siasos, Konstantinos Mourouzis, Evangelos Oikonomou, Manolis Vavuranakis, Georgia Vogiatzi, Alexandros Briasoulis, Nikolaos Papageorgiou, Theodore G. Papaioannou, Thodoris Zografos, Angeliki Papapanagiotou, Athanasios G. Papavassiliou, Christodoulos Stefanadis, Dimitris Tousoulis
Risk Factors for Cardiovascular Disease in Psoriasis: Relation to Inflammation Assessed by the Severity and Duration of Illness
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 12 Issue: 6 Year: 2013 Page: 385-390
Author(s): Andrea Bronhara Pelá Calamita,Zamir Calamita,João Carlos Ferreira Braga
The Timing of Drug Administration for Thromboprophylaxis Following Orthopaedic Surgery: Evidence and Controversies Related to Treatment Initiation and Duration
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 11-18
Author(s): Costas Papakostidis, Paul J. Harwood, Efthimios J. Karadimas, Hiang Boon Tan, Peter V. Giannoudis